Literature DB >> 19592658

IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines.

Ayele-Nati N Ahyi1, Hua-Chen Chang, Alexander L Dent, Stephen L Nutt, Mark H Kaplan.   

Abstract

Th2 cells can be subdivided into subpopulations depending on the level of a cytokine and the subsets of cytokines they produce. We have recently identified the ETS family transcription factor PU.1 as regulating heterogeneity in Th2 populations. To define additional factors that might contribute to Th2 heterogeneity, we examined the PU.1 interacting protein IFN-regulatory factor (IRF)4. When Th2 cells are separated based on levels of IL-10 secretion, IRF4 expression segregates into the subset of Th2 cells expressing high levels of IL-10. Infection of total Th2 cells, and IL-10 nonsecreting cells, with retrovirus-expressing IRF4, resulted in increased IL-4 and IL-10 expression, no change in IL-5 or IL-13 production and decreased Il9 transcription. Transfection of an IRF4-specific small interfering RNA into Th2 cells decreases IL-10 production. IRF4 directly binds the Il10 gene as evidenced by chromatin immunoprecipitation assay, and regulates Il10 control elements in a reporter assay. IRF4 interacts with PU.1, and in PU.1-deficient T cells there was an increase in IRF4 binding to the Il10 gene, and in the ability of IRF4 to induce IL-10 production compared with wild-type cells and Il10 promoter activity in a reporter assay. Further heterogeneity of IRF4 expression was observed in Th2 cells analyzed for expression of multiple Th2 cytokines. Thus, IRF4 promotes the expression of a subset of Th2 cytokines and contributes to Th2 heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592658      PMCID: PMC2734910          DOI: 10.4049/jimmunol.0803302

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

2.  Quantitative hydroxyl radical footprinting reveals cooperative interactions between DNA-binding subdomains of PU.1 and IRF4.

Authors:  P Gross; A A Yee; C H Arrowsmith; R B Macgregor
Journal:  Biochemistry       Date:  1998-07-07       Impact factor: 3.162

3.  Cooperative interaction between the DNA-binding domains of PU.1 and IRF4.

Authors:  A A Yee; P Yin; D P Siderovski; T W Mak; D W Litchfield; C H Arrowsmith
Journal:  J Mol Biol       Date:  1998-06-26       Impact factor: 5.469

4.  A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes.

Authors:  T Yamagata; J Nishida; S Tanaka; R Sakai; K Mitani; M Yoshida; T Taniguchi; Y Yazaki; H Hirai
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.

Authors:  N Rekhtman; F Radparvar; T Evans; A I Skoultchi
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

6.  The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines.

Authors:  J I Kim; I C Ho; M J Grusby; L H Glimcher
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

7.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.

Authors:  C F Eisenbeis; H Singh; U Storb
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

8.  Single cell analysis of cytokine gene coexpression during CD4+ T-cell phenotype development.

Authors:  R P Bucy; L Karr; G Q Huang; J Li; D Carter; K Honjo; J A Lemons; K M Murphy; C T Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10.

Authors:  F Gerosa; C Paganin; D Peritt; F Paiola; M T Scupoli; M Aste-Amezaga; I Frank; G Trinchieri
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.

Authors:  E Murphy; K Shibuya; N Hosken; P Openshaw; V Maino; K Davis; K Murphy; A O'Garra
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  72 in total

Review 1.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

Review 2.  Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6.

Authors:  Svetlana Chapoval; Preeta Dasgupta; Nicolas J Dorsey; Achsah D Keegan
Journal:  J Leukoc Biol       Date:  2010-03-24       Impact factor: 4.962

3.  NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Authors:  Melissa A Farrow; Eun-Young Kim; Steven M Wolinsky; Ann M Sheehy
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

4.  Kaposi's sarcoma-associated herpesvirus noncoding polyadenylated nuclear RNA interacts with virus- and host cell-encoded proteins and suppresses expression of genes involved in immune modulation.

Authors:  Cyprian C Rossetto; Gregory S Pari
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection.

Authors:  Takashi Satoh; Osamu Takeuchi; Alexis Vandenbon; Koubun Yasuda; Yoshiaki Tanaka; Yutaro Kumagai; Tohru Miyake; Kazufumi Matsushita; Toshihiko Okazaki; Tatsuya Saitoh; Kiri Honma; Toshifumi Matsuyama; Katsuyuki Yui; Tohru Tsujimura; Daron M Standley; Kenji Nakanishi; Kenta Nakai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-08-22       Impact factor: 25.606

6.  Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation.

Authors:  Shuyu Yao; Bruno Fernando Buzo; Duy Pham; Li Jiang; Elizabeth J Taparowsky; Mark H Kaplan; Jie Sun
Journal:  Immunity       Date:  2013-11-07       Impact factor: 31.745

7.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Cholera toxin directly enhances IL-17A production from human CD4+ T cells.

Authors:  Hsing-Chuan Tsai; Reen Wu
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

9.  An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia.

Authors:  Mathew A Cherian; Sydney Olson; Hemalatha Sundaramoorthi; Kitra Cates; Xiaogang Cheng; John Harding; Andrew Martens; Grant A Challen; Manoj Tyagi; Lee Ratner; Daniel Rauch
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

Review 10.  Programmed T cell differentiation: Implications for transplantation.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Cell Immunol       Date:  2020-03-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.